TEPADINA® 100mg/vial (thiotepa) is indicated as conditioning treatment prior to haematopoietic progenitor cell transplantation in haematological diseases and solid tumours.
Multiple indications in metastatic breast cancer, early breast cancer and metastatic gastric cancer
Multiple indications in Non-Hodgkin's lymphoma (NHL), Chronic lymphocytic leukaemia (CLL), Rheumatoid arthritis, Granulomatosis with polyangiitis and microscopic polyangiitis and Pemphigus vulgaris